Skip to main content
Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomas
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomas
User login
Username
Password
Reset your password
Type
Lead
score